Blog
RSS FeedPosted by Michael Wonder on 17 May 2026
New medicines may be out of reach of PBS patients as Australia fails to adapt to ‘seismic market shifts’
18 May 2026 - Donald Trump’s medicines prices policy is causing global market disruption even as Australia’s broken approval processes leave ...
Posted by Michael Wonder on 21 Apr 2026
PBS reform critical to accessing medical breakthroughs
20 April 2026 - We are witnessing an extraordinary medical revolution. Advances that once belonged in science fiction, like regenerative ...
Posted by Michael Wonder on 03 Apr 2026
MHRA-NICE pathway opens for business – everything you need to know to get started
1 April 2026 - Today marks a significant milestone for patients, the NHS and the pharmaceutical industry. From 1 April 2026, ...
Posted by Michael Wonder on 18 Mar 2026
Patients to get new medicines up to six months sooner
17 March 2026 - Patients in England are set to receive some new medicines 3 to 6 months earlier under a ...
Posted by Michael Wonder on 12 Feb 2026
Sick Australians risk being locked out of lifesaving medicines by outdated PBS
12 February 2026 - More medicines are successfully treating illness and disease, but Pfizer’s local boss says the PBS is falling ...
Posted by Michael Wonder on 11 Feb 2026
Canadians wait, on average, more than 65 weeks longer for access to new medicines than Europeans and 90 weeks more than Americans
10 February 2025 - Canadian patients are waiting, on average, more than 65 weeks longer than Europeans and over 90 ...
Posted by Michael Wonder on 30 Jan 2026
Canadians wait too long for access to innovative drugs, cautions the MEI
29 January 2026 - Pharmaceutical innovation is responsible for up to 66% of the increase in the age of death ...
Posted by Michael Wonder on 26 Jan 2026
Patient organisations welcome approval of six life-extending cancer treatments through Ontario's FAST Program, urge national expansion
23 January 2026 - Leading patient organisations are welcoming Ontario's announcement that six cancer drugs are now being fast-tracked for ...
Posted by Michael Wonder on 26 Jan 2026
AstraZeneca's Tagrisso and Calquence among first oncology treatments granted accelerated access through Ontario's FAST Program
23 January 2026 - AstraZeneca Canada is pleased to announce that Tagrisso (osimertinib) and Calquence (acalabrutinib tablets) are now publicly funded ...
Posted by Michael Wonder on 19 Jan 2026
Early access to supposedly innovative medicines: for a more informed bet
19 December 2025 - The evaluation of early access requests for medicines inherently involves a degree of uncertainty. Indeed, it relies ...
Posted by Michael Wonder on 29 Nov 2025
Government considers new PBS fund to slash wait times for treatments
29 November 2025 - The Albanese Government could introduce a new health fund by the next federal budget to bankroll ...
Posted by Michael Wonder on 11 Oct 2025
MHRA and NICE invite early adopters to trial accelerated aligned pathway – six months ahead of schedule
10 October 2025 - Aligned pathway will streamline decisions on licensing and value for medicines, helping patients to benefit from them ...
Posted by Michael Wonder on 08 Oct 2025
Ontario connecting patients to life-saving cancer drugs faster
7 October 2025 - The Ontario Government is leading the world in cancer care by launching the Funding Accelerated for ...
Posted by Michael Wonder on 08 Aug 2025
PBS wait times a more urgent issue than Donald Trump's potential pharmaceutical tariffs, peak medicines body warns
7 August 2025 - Excessive wait times for medicines to be listed on the PBS are a much greater threat ...
Posted by Michael Wonder on 06 Aug 2025
Patients to receive medicines 3 to 6 months faster under 10 year health plan
6 August 2025 - NICE and the MHRA have described how the 10 year health plan will lead to faster medicines ...